Published in J Med Chem on January 01, 1988
Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors. J Med Chem (2009) 0.98
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I. Eur J Nucl Med Mol Imaging (2006) 0.94
A photo-Favorskii ring contraction reaction: the effect of ring size. J Org Chem (2012) 0.81
Physical principles for economies of skilled movements. Biol Cybern (1983) 2.13
Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol (1986) 1.53
Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos (2008) 1.18
Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. Clin Pharmacol Ther (2007) 1.14
International variations in epidemiology of cancers of the extrahepatic biliary tract. Cancer Res (1985) 1.11
A NEW TYPE OF ACID CARBOHYDRATE FROM SEAWEED. Science (1928) 1.07
Variability in production of the vowels /i/ and /a/. J Acoust Soc Am (1985) 1.01
Confirmatory testing of Rotazyme results in neonates. J Pediatr (1985) 0.99
Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr (1988) 0.98
Coincident acquisition of Neisseria gonorrhoeae and HIV from fellatio. Lancet (1991) 0.96
Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6. Drug Metab Dispos (2001) 0.93
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther (1976) 0.88
Alpha adrenoreceptors of rabbit aorta and stomach fundus. J Pharmacol Exp Ther (1981) 0.86
Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of propranolol to 4'-hydroxypropranolol in the rat and in man. Drug Metab Dispos (1980) 0.85
Mandible movements during increasingly rapid articulations of single syllables: preliminary observations. J Acoust Soc Am (1984) 0.85
In vivo interaction of the enantiomers of disopyramide in human subjects. J Pharmacokinet Biopharm (1986) 0.85
Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6. Drug Metab Dispos (1995) 0.83
Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes. J Med Chem (1992) 0.83
The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study. Circulation (1982) 0.82
Synthesis of 4'- and 5'-hydroxyoxprenolol:pharmacologically active ring-hydroxylated metabolites of oxprenolol. J Med Chem (1979) 0.82
Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol analogs: metabolism by CYP1A2. Drug Metab Dispos (2001) 0.81
Simultaneous infection with Bordetella pertussis and respiratory syncytial virus in hospitalized children. Pediatr Infect Dis (1986) 0.81
A method for isolation of coenzyme A products. Anal Biochem (1968) 0.81
Carbinolamines, imines, and oxazolidines from fluorinated propranolol analogs. (19)F NMR and mass spectral characterization and evidence for formation as intermediates in cytochrome P450-catalyzed N-dealkylation. Drug Metab Dispos (2001) 0.81
Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol. Biochem Pharmacol (1990) 0.81
Synthesis and identification of the N-glucuronides of norgallopamil and norverapamil, unusual metabolites of gallopamil and verapamil. J Pharmacol Exp Ther (1990) 0.80
Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomes. Drug Metab Dispos (1993) 0.80
Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol. J Med Chem (1994) 0.80
Separation and quantitative determination of 2-acetyl-aminofluorene and its hydroxylated metabolites by high pressure liquid chromatography. Anal Biochem (1976) 0.80
The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site. J Mol Cell Cardiol (1986) 0.80
The role of biliary excretion in the hepatotoxicity of furosemide in the mouse. Toxicol Appl Pharmacol (1977) 0.79
Absolute configuration of glycerol derivatives. 7. Enantiomers of 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]methyl]-1,4-benzodioxane (WB-4101), a potent competitive alpha-adrenergic antagonist. J Med Chem (1979) 0.79
Enantioselective and diastereoselective hydroxylation of bufuralol. Absolute configuration of the 7-(1-hydroxyethyl)-2-[1-hydroxy-2-(tert-butylamino)ethyl]benzofurans, the benzylic hydroxylation metabolites. J Med Chem (1991) 0.79
Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes. Drug Metab Dispos (1990) 0.79
N-Dealkylation of propranolol: trapping of the 3-(1-naphthoxy)-2-hydroxypropionaldehyde formed in rat liver microsomes. Drug Metab Dispos (1982) 0.79
Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes. Drug Metab Dispos (1990) 0.79
(E)- and (Z)-7-arylidenenaltrexones: synthesis and opioid receptor radioligand displacement assays. J Med Chem (1997) 0.79
N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects. Drug Metab Dispos (1984) 0.79
The stereoselective disposition of disopyramide in the dog. J Cardiovasc Pharmacol (1981) 0.78
Blockade and postjunctional vascular alpha 1- and alpha 2-adrenoceptors in pithed rat by the enantiomers of WB-4101. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.78
Studies on Ca2+ channel antagonists. 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2- isopropylpentyl isothiocyanate, a chemoaffinity ligand derived from verapamil. J Med Chem (1986) 0.78
Pathways of propranolol metabolism. Use of the stable isotope twin-ion GC-MS technique to examine the conversion of propranolol to propranolol-diol by 9000g rat liver supernatant. Res Commun Chem Pathol Pharmacol (1978) 0.78
Conformational aspects of acetylcholine receptor sites. The isomeric 3-trimethylammonium-2-acetoxy-trans-decalin halides and the isomeric alpha,beta-dimethylacetylcholine halides. J Med Chem (1966) 0.78
Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures. Drug Metab Dispos (1986) 0.78
Stereoselective interactions of 2-[(2',6'-dimethoxyphenoxyethyl)aminomethyl]-1,4-benzodioxane (WB-4101) with the calcium channel. Biochem Pharmacol (1986) 0.78
Early postmarketing surveillance of betaxolol hydrochloride, September 1985-September 1986. Am J Ophthalmol (1987) 0.78
The relationship of ketamine requirement to age in pediatric patients. Anesthesiology (1974) 0.78
Stereoselectivity in the aromatic hydroxylation of propranolol in the rat: use of deuterium labeling and pseudoracemic mixtures. Drug Metab Dispos (1984) 0.78
Electrophysiology of the enantiomers of disopyramide in dogs. J Cardiovasc Pharmacol (1985) 0.78
State dependence of ethacizin and ethmozin block of sodium current in voltage clamped and internally perfused cardiac Purkinje cells. J Pharmacol Exp Ther (1990) 0.78
Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide. J Med Chem (1981) 0.77
The pharmacokinetics and pharmacodynamics of d- and dl-verapamil in rabbits. J Cardiovasc Pharmacol (1985) 0.77
Studies on Ca2+ channel antagonists. A 2-diazo-3,3,3-trifluoropropionamide derivative related to verapamil as a potential photoaffinity probe. J Med Chem (1990) 0.77
Regioisomeric aromatic dihydroxylation of propranolol. Synthesis and identification of 4,6- and 4,8-dihydroxypropranolol as metabolites in the rat and in man. Drug Metab Dispos (1988) 0.77
Electrophilic alpha-methylene-gamma-lactone and isothiocyanate opioid ligands related to etorphine. J Med Chem (1990) 0.76
Microsomal metabolism of furosemide evidence for the nature of the reactive intermediate involved in covalent binding. Mol Pharmacol (1976) 0.76
Resolution, absolute configuration, and antiarrhythmic properties of the enantiomers of disopyramide, 4-(diisopropylamino)-2-(2-pyridyl)-2-phenylbutyramide. J Med Chem (1980) 0.76
Phase II biotransformation of carcinogens/atherogens in cultured aortic tissues and cells. I. Sulfation of 3-hydroxy-benzo(a)pyrene. Drug Metab Dispos (1986) 0.76
Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction. Drug Metab Dispos (1986) 0.76
Comments on "Effect of cellular uncoupling by heptanol on conduction in infarcted myocardium". Circ Res (1990) 0.75
Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects. Drug Metab Dispos (1992) 0.75
Formation of the thiazoline ring in pantetheine. Biochemistry (1969) 0.75
Attempts to use cyanide ion to trap imine intermediates in the microsomal N-dealkylation of propranolol: formation of alpha-aminonitriles as artifacts when using ether for extraction. J Pharm Sci (1985) 0.75
Structure and research activities of pediatric infection control programs in the United States and Canada. Am J Infect Control (1986) 0.75
Aromatic hydroxylation of beta-adrenergic antagonists. 4- and 5-hydroxylation of 1-(isopropylamino)-3-[2-(allyloxy)phenoxy]-2-propanol (oxprenolol). J Med Chem (1978) 0.75
Circadian rhythms in polyamine excretion by rats bearing an immunocytoma. Chronobiologia (1977) 0.75
The structure of propranolol hemisuccinate. Res Commun Chem Pathol Pharmacol (1978) 0.75
Absolute configuration of glycerol derivatives.3.1 Synthesis and cupra A circular dichroism spectra of some chiral 3-aryloxy-1,2-propanediols and 3-aryloxy-1-amino-2-propanols. J Org Chem (1977) 0.75
Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition. Drug Metab Dispos (1994) 0.75
Aromatic hydroxylation of beta-adrenergic antagonists. Formation of 4'- and 5'-hydroxy-1-(isopropylamino)-3-[2'-allyloxy)phenoxy]-2-propanol from oxprenolol. J Med Chem (1979) 0.75
Hypoxic pulmonary vasoconstriction and the ratio of hypoxic lung to perfused normoxic lung. Anesthesiology (1978) 0.75
Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol. Drug Metab Dispos (1988) 0.75
Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium. J Pharmacol Exp Ther (1987) 0.75
Allergic events among health care workers exposed to psyllium laxatives in the workplace. J Occup Med (1987) 0.75
Characteristics of urinary circadian rhythms in a young man evaluated on a monthly basis during the course of 21 months. Chronobiologia (1974) 0.75
Structural requirements for mutagenic activity of 2-acylaminofluorenes in the Salmonella test system. Biochem Biophys Res Commun (1976) 0.75
Aromatic hydroxylation of propranolol. Stereochemical aspects of the formation of 4'-hydroxypropranolol in the rat. Res Commun Chem Pathol Pharmacol (1980) 0.75
Metabolism of beta-adrenergic antagonists. Evidence for an arene oxide-NIH shift pathway in the aromatic hydroxylation of oxprenolol. J Med Chem (1979) 0.75
Absolute configuration of glycerol derivatives. 4. Synthesis and pharmacological activity of chiral 2-alkylaminomethylbenzodioxans, competitive alpha-adrenergic antagonists. J Med Chem (1977) 0.75
Immunocytoma effect upon circadian variation in murine urinary excretion of beta-aminoisobutyric acid, beta-alanine, phenylalanine and tyrosine. Chronobiologia (1979) 0.75
Stereochemical analogs of a muscarinic, ganglionic stimulant. cis- and trans-4-(N-(3-chlorophenyl)carbamoyloxy)-2-butenyltrimethylammonium iodides. J Med Chem (1973) 0.75
Isothiocyanate-substituted kappa-selective opioid receptor ligands derived from N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl] phenylacetamide. J Med Chem (1994) 0.75
Centrally acting muscle relaxants. Isomeric 9,10-dihydroxy-1,2,3,4,4a,9,10,10a(trans-4a,10a)-octahydrophenanthrenes and their carbamate esters. J Med Chem (1974) 0.75
The developmental process of residency education. Issues of stress and happiness. Am J Dis Child (1985) 0.75
Electrophilic gamma-lactone kappa-opioid receptor probes. Analogues of 2'-hydroxy-2-tetrahydrofurfuryl-5,9-dimethyl-6,7-benzomorphan diastereomers. J Med Chem (1991) 0.75
Amphetamine derivatives: 10(e)- and 10(a)-amino-1,2,3,4,4a,9,10,10a-(trans-4a,10a)-octahydrophenanthrene. J Pharm Sci (1974) 0.75
Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro. Drug Metab Dispos (1988) 0.75
Facile method for the preparation of some novel bicyclic lactones. J Pharm Sci (1969) 0.75
Aromatic hydroxylation of oxprenolol. Quantitation and stereoselectivity in the formation of 4'- and 5-hydroxyoxprenolol in vivo in the rat. Res Commun Chem Pathol Pharmacol (1980) 0.75
Stereoselective binding of disopyramide to plasma proteins. Pharm Res (1988) 0.75
Alteration in the disposition and metabolism of S(-)-propranolol in rats with active respiratory viral infection. Life Sci (1988) 0.75
N-Hydroxyamide metabolites of lidocaine. Synthesis, characterization, quantitation, and mutagenic potential. J Med Chem (1978) 0.75
Electrophilic opioid ligands. Oxygen tethered alpha-methylene-gamma-lactone, acrylate, isothiocyanate, and epoxide derivatives of 6 beta-naltrexol. J Med Chem (1992) 0.75
Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6 alpha- and 6 beta-naltrexol. J Med Chem (1990) 0.75
Fluorinated phenytoin anticonvulsant analogs. J Pharm Sci (1979) 0.75
Chemical and stereochemical aspects of propranolol metabolism. Diastereomeric 1-(1-hydroxy-2-propylamino)-3-(1-naphthoxy)-2-propanols produced by rat liver microsomal omega-hydroxylation. J Med Chem (1986) 0.75